Literature DB >> 16739027

A dyad symmetry element in the fibroblast growth factor-2 gene promoter with different levels of activity in astrocytoma and hepatocelluar carcinoma cell lines.

Tetsuya Ueba1, Hisae Mori, Jun A Takahashi, Kazuhiko Nozaki, Nobuo Hashimoto.   

Abstract

Fibroblast growth factor-2 (FGF-2) gene expression is reported to be spatially and temporally regulated in the process of development, normal growth, and wound healing. We postulated that its constitutive expression in human malignant astrocytoma cells is due to loss of function of the regulatory mechanism of FGF-2 gene expression. Here, we report the characterization of a unique element in the FGF-2 gene promoter. We investigated the transcriptional regulation of the FGF-2 gene in a human malignant astrocytoma (U87MG) and a human hepatocellular carcinoma (HepG2) cell line. We found that a dyad symmetry element (DSE) in the FGF-2 gene promoter exhibited different promoter activities; in HepG2 cells it did, while in U87MG cells it did not, exhibit repressive activity. Examination of the relative promoter activities of the DSE in a thymidine kinase promoter revealed it exerted different activities, just as it did in the 2 cell lines studied. Gel shift assay demonstrated that 2 proteins bound to the DSE in nuclear extracts from HepG2 cells and that one protein was missing in nuclear extracts from U87MG cells. These results suggest that the DSE has a crucial role as a transcriptional regulatory element of FGF-2 gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16739027     DOI: 10.1007/s11060-005-9063-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  24 in total

Review 1.  Oncogenes and tumor suppressor genes.

Authors:  E Liu; B Weissman
Journal:  Cancer Treat Res       Date:  1992

Review 2.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

3.  CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements.

Authors:  B Luckow; G Schütz
Journal:  Nucleic Acids Res       Date:  1987-07-10       Impact factor: 16.971

4.  Basic fibroblast growth factor transcriptional autoregulation requires EGR-1.

Authors:  D Wang; M W Mayo; A S Baldwin
Journal:  Oncogene       Date:  1997-05-15       Impact factor: 9.867

Review 5.  Eukaryotic transcriptional regulatory proteins.

Authors:  P F Johnson; S L McKnight
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

6.  Repression of human fibroblast growth factor 2 by a novel transcription factor.

Authors:  T Ueba; B Kaspar; X Zhao; F H Gage
Journal:  J Biol Chem       Date:  1999-04-09       Impact factor: 5.157

7.  Immunohistochemical localization of basic fibroblast growth factor in astrocytomas.

Authors:  D Zagzag; D C Miller; Y Sato; D B Rifkin; D E Burstein
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

8.  Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells.

Authors:  T Ueba; T Nosaka; J A Takahashi; F Shibata; R Z Florkiewicz; B Vogelstein; Y Oda; H Kikuchi; M Hatanaka
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

9.  Transcriptional regulation of fibroblast growth factor-2 expression in human astrocytes: implications for cell plasticity.

Authors:  J Moffett; E Kratz; J Myers; E K Stachowiak; R Z Florkiewicz; M K Stachowiak
Journal:  Mol Biol Cell       Date:  1998-08       Impact factor: 4.138

10.  Promoter regions involved in density-dependent regulation of basic fibroblast growth factor gene expression in human astrocytic cells.

Authors:  J Moffett; E Kratz; R Florkiewicz; M K Stachowiak
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

View more
  1 in total

1.  Basic fibroblast growth factor in an animal model of spontaneous mammary tumor progression.

Authors:  Steven Kao; Jeffrey Mo; Andrew Baird; Brian P Eliceiri
Journal:  Oncol Rep       Date:  2012-03-07       Impact factor: 3.906

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.